Literature DB >> 16399309

Intermediate outcomes after the Fontan procedure in the current era.

Michael E Mitchell1, Richard F Ittenbach, J William Gaynor, Gil Wernovsky, Susan Nicolson, Thomas L Spray.   

Abstract

OBJECTIVE: This study was undertaken to investigate the intermediate outcomes after the Fontan operation in the current era.
METHODS: A cross-sectional analysis was performed by using data gathered between October 13, 2003, and February 22, 2005, on all 310 survivors of the Fontan procedure between January 1, 1992, and December 31, 1999. Medical records were reviewed, and a customized questionnaire was administered to caregivers. Outcome variables included failure of the Fontan operation (ie, death, takedown of Fontan, or transplantation), number of cardiac-related rehospitalizations, parental assessment of health, school performance, and cardiac functional status.
RESULTS: A total of 332 patients underwent the Fontan procedure during the study period. A lateral tunnel was constructed in 281 (85%), and an extracardiac Fontan procedure was performed in 51 (15%). A total of 210 (63%) children had undergone previous stage I reconstruction, and 162 (49%) had received an initial diagnosis of hypoplastic left heart syndrome. There were 310 hospital survivors of the Fontan procedure (93.4%), with an additional 16 deaths (5.2%) during follow-up and 1 living heart transplant patient before the cross-sectional period. For initial hospital survivors, Kaplan-Meier estimates of freedom from death or transplantation were 98.0% (95% confidence interval, 95.6%-99.1%) at 1 year after the Fontan procedure, 94.9% (91.6%-97.0%) at 5 years, and 93.9% (90.1%-96.2%) at 8 years. Questionnaires were completed for 240 (81.9%) of the 293 available patients. By parental recollection, a total of 130 (54.2%) children required cardiac-related rehospitalization at some point during the follow-up period. At a median follow-up of 8.6 years (range, 4.1-12.8 years), 94.6% of guardians described their child's overall health as excellent or good, and 5.4%, as fair or poor. School performance was described as above average in 30.2%, average in 39.9%, and below average in 29.8%. With regard to cardiac functional status, 34.2% responded that their child had no limitations to physical activity, 52.5% reported a slight limitation, 12.1% reported a significant limitation, and 1.2% reported a severe limitation.
CONCLUSIONS: Acceptable survival outcomes have been observed at intermediate follow-up of the Fontan operation in this cohort; a significant proportion of patients had hypoplastic left heart syndrome. Although cardiac-related rehospitalization is common, the parents and guardians believed that overall health, school performance, and cardiac functional status were good to excellent for most patients.

Entities:  

Mesh:

Year:  2005        PMID: 16399309     DOI: 10.1016/j.jtcvs.2005.08.047

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Intermediate-Term Results After Extracardiac Conduit Fontan Palliation in Children and Young Adults with Single Ventricle Physiology-A Single-center Experience.

Authors:  Shashi Raj; Eliot Rosenkranz; Barbara Sears; Sethuraman Swaminathan
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

2.  Counseling Practices for Fetal Hypoplastic Left Heart Syndrome.

Authors:  Michael J Walsh; George R Verghese; M Eric Ferguson; Nora F Fino; David J Goldberg; Sonal T Owens; Nelangi Pinto; Sinai C Zyblewski; Michael D Quartermain
Journal:  Pediatr Cardiol       Date:  2017-03-27       Impact factor: 1.655

Review 3.  Heart failure in single right ventricle congenital heart disease: physiological and molecular considerations.

Authors:  Anastacia M Garcia; Jonathan-Thomas Beatty; Stephanie J Nakano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-28       Impact factor: 4.733

4.  Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial.

Authors:  William T Mahle; Chenwei Hu; Felicia Trachtenberg; JonDavid Menteer; Steven J Kindel; Anne I Dipchand; Marc E Richmond; Kevin P Daly; Heather T Henderson; Kimberly Y Lin; Michael McCulloch; Ashwin K Lal; Kurt R Schumacher; Jeffrey P Jacobs; Andrew M Atz; Chet R Villa; Kristin M Burns; Jane W Newburger
Journal:  J Heart Lung Transplant       Date:  2018-02-16       Impact factor: 10.247

5.  Prenatal diagnosis of hypoplastic left heart syndrome: impact of counseling patterns on parental perceptions and decisions regarding termination of pregnancy.

Authors:  Debra Hilton-Kamm; Ruey-Kang Chang; Mark Sklansky
Journal:  Pediatr Cardiol       Date:  2012-05-23       Impact factor: 1.655

6.  Hemodynamic performance of stage-2 univentricular reconstruction: Glenn vs. hemi-Fontan templates.

Authors:  Kerem Pekkan; Lakshimi P Dasi; Diane de Zélicourt; Kartik S Sundareswaran; Mark A Fogel; Kirk R Kanter; Ajit P Yoganathan
Journal:  Ann Biomed Eng       Date:  2008-11-06       Impact factor: 3.934

7.  Patient-specific surgical planning and hemodynamic computational fluid dynamics optimization through free-form haptic anatomy editing tool (SURGEM).

Authors:  Kerem Pekkan; Brian Whited; Kirk Kanter; Shiva Sharma; Diane de Zelicourt; Kartik Sundareswaran; David Frakes; Jarek Rossignac; Ajit P Yoganathan
Journal:  Med Biol Eng Comput       Date:  2008-08-05       Impact factor: 2.602

8.  Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients.

Authors:  Lindsay R Freud; Doff B McElhinney; Audrey C Marshall; Gerald R Marx; Kevin G Friedman; Pedro J del Nido; Sitaram M Emani; Terra Lafranchi; Virginia Silva; Louise E Wilkins-Haug; Carol B Benson; James E Lock; Wayne Tworetzky
Journal:  Circulation       Date:  2014-07-22       Impact factor: 29.690

Review 9.  Modeling the Fontan circulation: where we are and where we need to go.

Authors:  C G DeGroff
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

10.  Ethics of cardiac transplantation in hypoplastic left heart syndrome.

Authors:  Alexander A Kon
Journal:  Pediatr Cardiol       Date:  2009-04-25       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.